Viral Vectors & Plasmid DNA Global Market Report 2020-30: Covid 19 Implications and Growth
July 16, 2020 09:16 ET
|
ReportLinker
New York, July 16, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Viral Vectors & Plasmid DNA Global Market Report 2020-30: Covid 19 Implications and Growth" -...
WindMIL Therapeutics and Cognate BioServices Announce Agreement to Expand MILs Manufacturing Capacity
March 10, 2020 07:00 ET
|
WindMIL Therapeutics; Cognate BioServices , Inc.
PHILADELPHIA, BALTIMORE, and MEMPHIS, Tenn., March 10, 2020 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs™) for cancer...
Stem Cell Research Markets & Products, 2019 & 2020-2024, Featuring Competitive Analysis for 128 Global Market Participants
January 08, 2020 11:28 ET
|
Research and Markets
Dublin, Jan. 08, 2020 (GLOBE NEWSWIRE) -- The "Stem Cell Research Products 2020 - Opportunities, Tools, & Technologies" report has been added to ResearchAndMarkets.com's offering. ...
American Gene Technologies to Present at 2019 Cell & Gene Meeting on the Mesa
October 01, 2019 14:51 ET
|
American Gene Technologies
ROCKVILLE, Md., Oct. 01, 2019 (GLOBE NEWSWIRE) -- American Gene Technologies announced today that its Chief Science Officer C. David Pauza, Ph.D. will present at the annual Cell & Gene Meeting...
WindMIL Therapeutics to Present at 2019 Cell & Gene Meeting on the Mesa
September 30, 2019 07:00 ET
|
WindMIL Therapeutics
BALTIMORE, Md. and PHILADELPHIA, Sept. 30, 2019 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs™) for cancer immunotherapy,...
Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal Clinical Trial of CLBS14 in No-option Refractory Disabling Angina
August 07, 2019 08:30 ET
|
Caladrius Biosciences, Inc.
BASKING RIDGE, N.J. and MEMPHIS, Tenn., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development...
The Alliance for Regenerative Medicine Announces Agenda and Legislator of the Year Award Recipients for Ninth Annual Dinner and Legislative Fly-In
May 15, 2018 10:05 ET
|
Alliance for Regenerative Medicine
WASHINGTON, DC, May 15, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) announced the speaker line up for its ninth Annual Dinner and Legislative Fly-In, to be held May 22 and...
The Alliance for Regenerative Medicine Releases Complete Agenda for Sixth Annual Cell & Gene Therapy Investor Day
March 28, 2018 10:47 ET
|
Alliance for Regenerative Medicine
WASHINGTON, DC, March 28, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today released the complete agenda for its upcoming sixth annual Cell & Gene Therapy Investor Day,...
Global Market For Cell Therapy Manufacturing 2017
July 21, 2017 09:05 ET
|
Research and Markets
Dublin, July 21, 2017 (GLOBE NEWSWIRE) -- The "The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, Distribution, & More" report has been...
Biopharmaceutical Contract Manufacturing Market, 2027
July 06, 2017 11:28 ET
|
Research and Markets
Dublin, July 06, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Biopharmaceutical Contract Manufacturing Market (2nd Edition), 2017-2027" report to...